Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation.
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
10
9
2024
Statut:
aheadofprint
Résumé
This Clinical Practice Update provides revised guidance on Rh testing and Rh D immune globulin administration for individuals undergoing abortion or experiencing pregnancy loss at less than 12 0/7 weeks of gestation. This document updates Practice Bulletin No. 225, Medication Abortion Up to 70 Days of Gestation (Obstet Gynecol 2020;136:e31-47); Practice Bulletin No. 200, Early Pregnancy Loss (Obstet Gynecol 2018;132:e197-207); and Practice Bulletin No. 181, Prevention of Rh D Alloimmunization (Obstet Gynecol 2017;130:e57-70).
Identifiants
pubmed: 39255498
doi: 10.1097/AOG.0000000000005733
pii: 00006250-990000000-01145
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Chan MC, Gill RK, Kim CR. Rhesus isoimmunisation in unsensitised RhD-negative individuals seeking abortion at less than 12 weeks' gestation: a systematic review. BMJ Sex Reprod Health 2022;48:163–8. doi: 10.1136/bmjsrh-2021-201225
doi: 10.1136/bmjsrh-2021-201225
Karanth L, Jaafar SH, Kanagasabai S, Nair NS, Barua A. Anti‐D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation. The Cochrane Database Systematic Reviews 2013, Issue 3. Art. No.: CD009617. doi: 10.1002/14651858.CD009617.pub2
Jabara S, Barnhart KT. Is Rh immune globulin needed in early first-trimester abortion? A review. Am J Obstet Gynecol 2003;188:623–7. doi: 10.1067/mob.2003.208
doi: 10.1067/mob.2003.208
International Federation of Gynecology and Obstetrics. FIGO consensus statement: uterine evacuation. Accessed August 6, 2024. https://www.figo.org/news/figo-consensus-statement-uterine-evacuation
World Health Organization. Abortion care guideline. Accessed August 6, 2024. https://iris.who.int/bitstream/handle/10665/349316/9789240039483-eng.pdf
Royal College of Obstetricians and Gynaecologists. Best practice in abortion care. Making abortion safe. Accessed August 6, 2024. https://www.rcog.org.uk/media/geify5bx/abortion-care-best-practice-paper-april-2022.pdf
National Abortion Federation. Clinical policy guidelines for abortion care. Accessed August 6, 2024. https://prochoice.org/providers/quality-standards/
Horvath S, Huang Z, Koelper NC, Martinez C, Tsao PY, Zhao L, et al. Induced abortion and the risk of Rh sensitization. JAMA 2023;330:1167–74. doi: 10.1001/jama.2023.16953
doi: 10.1001/jama.2023.16953
Horvath S, Tsao P, Huang Z, Zhao L, Du Y, Sammel MD, et al. The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization. Contraception 2020;102:1–6. doi: 10.1016/j.contraception.2020.02.011
doi: 10.1016/j.contraception.2020.02.011
Wiebe ER, Campbell M, Aiken AR, Albert A. Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and the Netherlands. Contracept X 2018;1:100001. doi: 10.1016/j.conx.2018.100001
doi: 10.1016/j.conx.2018.100001
Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, Clarke G. Guideline no. 448: prevention of Rh D alloimmunization. J Obstet Gynaecol Can 2024;46:102449. doi: 10.1016/j.jogc.2024.102449
doi: 10.1016/j.jogc.2024.102449
Horvath S, Goyal V, Traxler S, Prager S. Society of Family Planning committee consensus on Rh testing in early pregnancy. Contraception 2022;114:1–5. doi: 10.1016/j.contraception.2022.07.002
doi: 10.1016/j.contraception.2022.07.002
Prevention of Rh D alloimmunization. Practice Bulletin No. 181. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e57–70. doi: 10.1097/AOG.0000000000002232
doi: 10.1097/AOG.0000000000002232
National Institute for Health and Care Excellence. Abortion care. NICE guideline [NG140]. Accessed August 6, 2024. https://www.nice.org.uk/guidance/ng140
National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE guideline [NG126]. Accessed August 6, 2024. https://www.nice.org.uk/guidance/ng126
Visser GH, Thommesen T, Di Renzo GC, Nassar AH, Spitalnik SL. FIGO/ICM guidelines for preventing Rhesus disease: a call to action. FIGO Committee for Safe Motherhood, Newborn Health. Int J Gynaecol Obstet 2021;152:144–7. doi: 10.1002/ijgo.13459
doi: 10.1002/ijgo.13459
Prabhu M, Louis JM, Kuller JA. Society for Maternal-Fetal Medicine statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation. SMFM Publications Committee. Am J Obstet Gynecol 2024;230:B2–5. doi: 10.1016/j.ajog.2024.02.288
doi: 10.1016/j.ajog.2024.02.288
American College of Obstetricians and Gynecologists. The Rh factor: how it can affect your pregnancy. Frequently asked questions. Accessed August 6, 2024. https://www.acog.org/womens-health/faqs/the-rh-factor-how-it-can-affect-your-pregnancy